Gri Bio, Inc.
Get Full AccessDescription
- GRI is a development stage biotech company fundamentally changing the way inflammatory disease is treated. GRIs Natural Killer T (NKT) cell-based therapies are being developed for liver disease and acute liver failure. NKT cells share properties of both NK and T cells and are a functional link between the innate and adaptive immune responses. Type 1 NKT cells play a critical role in initiating and propagating the inflammatory response and the hepatic injury that is observed in liver disease. GRIs lead program, GRI-0621, is an inhibitor of type I NKT cells and is being developed as a novel oral therapeutic for acute liver failure.
-
Headquarters:8954 Rio San Diego Drive Suite 102, San Diego, California, United States
More -
Phone Number: +1 619-400-1170
-
Website: https://www.gribio.com
-
Employees:6
-
Revenue:$1 - 10M
-
Legal Name:Gri Bio, Inc.
-
Gri Bio, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Gri Bio, Inc.
-
Where are Gri Bio, Inc.'s Headquarters?
Gri Bio, Inc.'s Headquarters are in 8954 Rio San Diego Drive Suite 102,San Diego,California,United States
-
What is Gri Bio, Inc.'s phone number?
Gri Bio, Inc.'s phone number is +1 619-400-1170
-
What is Gri Bio, Inc.'s official website?
Gri Bio, Inc.'s official website is https://www.gribio.com
-
What is Gri Bio, Inc.'s Revenue?
Gri Bio, Inc.'s revenue is $1 - 10M
-
What is Gri Bio, Inc.'s NAICS code?
Gri Bio, Inc.'s NAICS code is 541713
-
How many employees are working in Gri Bio, Inc.
Gri Bio, Inc. has 6 employees
-
What is Gri Bio, Inc.'s Industry?
Gri Bio, Inc. is in the industry of Biotechnology
-
Who is Gri Bio, Inc.'s CEO?
Gri Bio, Inc.'s CEO is Marc Hertz

